ng-nitroarginine methyl ester has been researched along with Choroid Neovascularization in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connolly, E; Gragoudas, ES; Hafezi-Moghadam, A; Hisatomi, T; Matsubara, A; Michaud, N; Miller, JW; Nakazawa, T; She, H; Young, TA | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and Choroid Neovascularization
| Article | Year |
|---|---|
Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization.
Topics: Animals; Apoptosis; Caspase 3; Choroidal Neovascularization; Disease Models, Animal; Enzyme Inhibitors; Fluorescein Angiography; Fluorescent Antibody Technique, Indirect; In Situ Nick-End Labeling; Injections, Intraperitoneal; Macaca fascicularis; Macrophages; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Photochemotherapy; Photoreceptor Cells, Vertebrate; Photosensitizing Agents; Porphyrins; Rats; Rats, Inbred BN; Retinal Degeneration; Verteporfin | 2007 |